 Covey Capital Advisors LLC purchased a new position in shares of  Amrize Ltd (NYSE:AMRZ – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 23,726 shares of the company’s stock, valued at approximately $1,176,000. Amrize comprises approximately  1.3% of Covey Capital Advisors LLC’s holdings, making the stock its 23rd biggest holding.
Covey Capital Advisors LLC purchased a new position in shares of  Amrize Ltd (NYSE:AMRZ – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 23,726 shares of the company’s stock, valued at approximately $1,176,000. Amrize comprises approximately  1.3% of Covey Capital Advisors LLC’s holdings, making the stock its 23rd biggest holding. 
Several other hedge funds also recently modified their holdings of AMRZ. Credit Industriel ET Commercial acquired a new stake in shares of Amrize in the second quarter worth $109,000. Private Capital Advisors Inc. acquired a new stake in Amrize in the 2nd quarter worth $233,000. Cullen Frost Bankers Inc. acquired a new stake in Amrize in the 2nd quarter worth $244,000. Virtus Family Office LLC bought a new position in shares of Amrize during the 2nd quarter worth about $253,000. Finally, FNY Investment Advisers LLC acquired a new position in shares of Amrize during the second quarter valued at about $372,000.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on AMRZ. UBS Group lifted their target price on Amrize from $49.00 to $52.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 14th. JPMorgan Chase & Co. boosted their price objective on Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research report on Tuesday, August 26th. Barclays began coverage on Amrize in a research note on Tuesday, October 7th. They issued an “equal weight” rating for the company. Morgan Stanley set a $61.00 price target on shares of Amrize and gave the stock an “overweight” rating in a research note on Wednesday. Finally, Royal Bank Of Canada lowered their price target on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $58.14.
Amrize Trading Down 1.8%
Shares of AMRZ opened at $51.90 on Friday. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $56.29. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.85 and a current ratio of 1.38. The stock has a 50 day moving average of $50.60. The firm has a market cap of $28.71 billion and a PE ratio of 66.54.
Amrize (NYSE:AMRZ – Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The business had revenue of $3.22 billion during the quarter.
Insider Buying and Selling at Amrize
In other news, insider Mario Gross acquired 3,000 shares of the firm’s stock in a transaction on Wednesday, August 13th. The shares were purchased at an average cost of $49.63 per share, with a total value of $148,890.00. Following the completion of the purchase, the insider owned 23,232 shares of the company’s stock, valued at $1,153,004.16. This represents a 14.83% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Stephen S. Clark acquired 5,000 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were purchased at an average cost of $51.82 per share, with a total value of $259,100.00. Following the acquisition, the insider owned 5,000 shares of the company’s stock, valued at approximately $259,100. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 1,124,000 shares of company stock worth $53,225,260 over the last ninety days.
Amrize Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Read More
- Five stocks we like better than Amrize
- What is a Secondary Public Offering? What Investors Need to Know
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- About the Markup Calculator
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- What Are Growth Stocks and Investing in Them
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						